A
LLY icon

Allianz’s Eli Lilly LLY Stock Holding History

Allianz’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38M Buy
31,653
+2,071
+7% +$2.12M 0.4% 33
2026
Q1 		$27.2M Sell
29,582
-12,334
-29% -$12.5M 0.3% 34
2025
Q4 		$45M Buy
41,916
+2,326
+6% +$2.22M 0.58% 28
2025
Q3 		$30.2M Sell
39,590
-909
-2% -$676K 0.64% 27
2025
Q2 		$31.6M Buy
40,499
+1,298
+3% +$1.01M 0.75% 24
2025
Q1 		$32.4M Buy
39,201
+1,324
+3% +$1.1M 0.86% 21
2024
Q4 		$29.3M Buy
37,877
+744
+2% +$616K 0.76% 24
2024
Q3 		$32.9M Buy
37,133
+1,483
+4% +$1.33M 0.89% 21
2024
Q2 		$32.3M Sell
35,650
-1,023
-3% -$818K 0.95% 19
2024
Q1 		$28.5M Buy
+36,673
New +$26.1M 0.9% 20

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Allianz's LLY Position: Q2 2026 in Review

Allianz increased its Eli Lilly (LLY) stake by 7% in Q2 2026, buying an estimated $2.12M and bringing the position to 31,653 shares worth $38M. The position accounts for 0.4% of the portfolio, ranked #33.

Allianz first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $45M in Q4 2025. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Allianz held 31,653 shares of Eli Lilly worth $38M as of Q2 2026.
  • Allianz bought 2,071 Eli Lilly shares in Q2 2026, an estimated $2.12M.
  • Eli Lilly made up 0.4% of Allianz's portfolio in Q2 2026, its #33 holding.
  • Allianz first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Eli Lilly position peaked at $45M in Q4 2025.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.